Alpha-1 blocker tablets for benign prostatic hyperplasia and hypertension, supplied by multinational pharmaceutical companies to urology and cardiology departments. B2B distribution networks facilitate procurement by healthcare providers for dual-indication therapeutic use in ambulatory care.